Related references
Note: Only part of the references are listed.Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016
Carsten Hjorthoj et al.
PSYCHOLOGICAL MEDICINE (2021)
The Potential Impact of Recreational Cannabis Legalization on the Prevalence of Cannabis Use Disorder and Psychotic Disorders: A Retrospective Observational Study: L'effet potentiel de la legalisation du cannabis recreatif sur la prevalence du trouble d'utilisation du cannabis et des troubles psychotiques : une etude observationnelle retrospective
Catherine Vignault et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2021)
Impacts of Canada's cannabis legalization on police-reported crime among youth: early evidence
Russell C. Callaghan et al.
ADDICTION (2021)
Are we any closer to identifying a causal relationship between cannabis and psychosis?
Ian Hamilton et al.
CURRENT OPINION IN PSYCHOLOGY (2021)
Cannabis use and psychosis: a review of reviews
Alkomiet Hasan et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review
Sanne J. van der Steur et al.
BRAIN SCIENCES (2020)
Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies
Suhas Ganesh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?
Robin M. Murray et al.
JAMA PSYCHIATRY (2020)
Psychotic disorder and cannabis use: Canadian hospitalization trends, 2006-2015
Bridget Maloney-Hall et al.
HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION IN CANADA-RESEARCH POLICY AND PRACTICE (2020)
Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems
Russell C. Callaghan et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation
Syed Mahamad et al.
DRUG AND ALCOHOL REVIEW (2020)
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
Guy Hindley et al.
LANCET PSYCHIATRY (2020)
International incidence of psychotic disorders, 2002-17: a systematic review and meta-analysis
Hannah E. Jongsma et al.
LANCET PUBLIC HEALTH (2019)
Cannabis legalization: Did we make a mistake? Update 2019
Marco Leyton
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2019)
Increasing potency and price of cannabis in Europe, 2006-16
Tom P. Freeman et al.
ADDICTION (2019)
Cannabis legalization: progress in harm reduction approaches for substance use and misuse
Bryon Adinoff et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Benedikt Fischer et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2017)
Evaluating the public health impacts of legalizing recreational cannabis use in the United States
Wayne Hall et al.
ADDICTION (2016)
Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis
Tabea Schoeler et al.
LANCET PSYCHIATRY (2016)
Normalization and denormalization in different legal contexts: Comparing cannabis and tobacco
Mark Asbridge et al.
DRUGS-EDUCATION PREVENTION AND POLICY (2016)
Simulation methods to estimate design power: an overview for applied research
Benjamin F. Arnold et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database
Hude Quan et al.
HEALTH SERVICES RESEARCH (2008)
Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia
Louisa Degenhardt et al.
MEDICAL JOURNAL OF AUSTRALIA (2007)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
Share Paper
